Equine protozoal myeloencephalitis (EPM) is a serious neurological disease and a common cause of ataxia (lack of coordinated movements) and weakness in horses. The causative agent of EPM is Sarcocystis neurona, a protozoan parasite that infects
Lameness ranks as the most expensive health issue for horse owners nationwide (as compared to colic and EPM), according to the United States Department of Agriculture’s National Animal Health Monitoring System (NAHMS) Equine ’98 Study. NAHMS
The U.S. Department of Agriculture announced on Dec. 18 that it had issued a conditional license to Fort Dodge Laboratories, Inc., of Fort Dodge, Iowa, a division of American Home Products, Inc., for a vaccine intended to aid in
Your horse was diagnosed with equine protozoal myeloencephalitis, but with quick intervention by your veterinarian, careful administration of medications, and lots of nursing, he is on his way to recovery and being cured of the”P align=left>
At first, veterinarians and researchers were scrambling to discover anything about the “new” neurologic disease that was causing such a stir in the horse industry. The disease, equine protozoal myeloencephalitis (EPM), was discovered to be cause
Viral infections of the equine respiratory tract are a veterinary challenge. They occur frequently and result in major economic loss to the horse industry. Currently available vaccines are not completely effective in controlling respiratory
The Food and Drug Administration is allowing licensed veterinarians to submit a request to be allowed to import Diclazuril from Canada to treat horses affected by equine protozoal myeloencephalitis (EPM). Diclazuril is licensed for use in Canada
Stay on top of the most recent Horse Health news with
